Medicines in ATC group L — Antineoplastic and immunomodulating agents

Overview of medicines in ATC class L (Antineoplastic and immunomodulating agents) and their availability in Belgian pharmacies.

1857 medicines

• Revlimid 25 mg — lenalidomide
• Revlimid 5 mg — lenalidomide
• Revlimid 5 mg — lenalidomide
• Revlimid 7.5 mg — lenalidomide
• Rinvoq 15 mg — upadacitinib
• Rinvoq 15 mg — upadacitinib
• Rinvoq 15 mg — upadacitinib
• Rinvoq 30 mg — upadacitinib
• Rinvoq 30 mg — upadacitinib
• Rinvoq 45 mg — upadacitinib
• Riulvy 174 mg — tegomilfumaraat
• Riulvy 348 mg — tegomilfumaraat
• Riulvy 348 mg — tegomilfumaraat
• Rixathon 100 mg — rituximab
• Rixathon 500 mg — rituximab
• Rixathon 500 mg — rituximab
• RoActemra 162 mg — tocilizumab
• RoActemra 162 mg — tocilizumab
• RoActemra 20 mg/ml — tocilizumab
• RoActemra 20 mg/ml — tocilizumab
• RoActemra 20 mg/ml — tocilizumab
• Roferon-A 3 10*6 IU
• Roferon-A 6 10*6 IU
• Roferon-A 9 10*6 IU
• Rozlytrek 100 mg — entrectinib
• Rozlytrek 200 mg — entrectinib
• Rozlytrek 200 mg — entrectinib
• Rozlytrek 200 mg — entrectinib
• Rozlytrek 50 mg — entrectinib
• Rubraca 200 mg — rucaparib
• Rubraca 250 mg — rucaparib
• Rubraca 300 mg — rucaparib
• Ruxience 100 mg — rituximab
• Ruxience 500 mg — rituximab
• Rybrevant 1600 mg — amivantamab
• Rybrevant 2240 mg — amivantamab
• Rybrevant 350 mg — amivantamab
• Rydapt 25 mg — midostaurine
• Rystiggo 140 mg/ml — rozanolixizumab
• Rystiggo 140 mg/ml — rozanolixizumab
• Salvacyl 11.25 mg — triptoreline
• Sandimmun 250 mg/5 ml — ciclosporine
• Saphnelo 300 mg — anifrolumab
• Sarclisa 20 mg/ml
• Sarclisa 20 mg/ml
• Sarclisa 20 mg/ml
• Scemblix 20 mg — asciminib
• Scemblix 40 mg — asciminib
• Siklos 100 mg — hydroxycarbamide
• Simponi 100 mg — golimumab
• Simponi 100 mg — golimumab
• Simponi 50 mg — golimumab
• Simponi 50 mg — golimumab
• Simponi 50 mg — golimumab
• Simponi 50 mg — golimumab
• Simponi 50 mg — golimumab
• Simponi 50 mg — golimumab
• Simponi 50 mg — golimumab
• Simponi 50 mg — golimumab
• Simulect 20 mg — basiliximab